R. Loch Macdonald, Chief Scientific Officer at Edge Therapeutics, Inc. (EDGE), sold 12,500 shares at $13.82 ($174K) on 2018-02-21, disclosed to the SEC on 2018-02-22.
Open-market sale of $174k EDGE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.75 | 5,000 | $69K | 39.5% |
| 2 | $13.82 | 5,000 | $69K | 39.7% |
| 3 | $14.49 | 2,500 | $36K | 20.8% |
| Total | $13.93 avg | 12,500 | $174K | 100% |
| Filing → |